Related references
Note: Only part of the references are listed.Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
Naoki Iwamoto et al.
Modern Rheumatology (2014)
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis
Dirk Holzinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study
Joachim Gerss et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
Maja Bulatovic et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
Carol A. Wallace et al.
ARTHRITIS AND RHEUMATISM (2012)
Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure
Jaap Fransen et al.
PHARMACOGENOMICS (2012)
Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO
Kirsten Minden et al.
RHEUMATOLOGY (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis
Anne Hinks et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Ongoing Disease Activity and Changing Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis
Ellen Nordal et al.
ARTHRITIS AND RHEUMATISM (2011)
Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission A Randomized Clinical Trial
Dirk Foell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype
Halima Moncrieffe et al.
PHARMACOGENETICS AND GENOMICS (2010)
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study
Kimme L. Hyrich et al.
RHEUMATOLOGY (2010)
Abatacept Improves Health-Related Quality of Life, Pain, Sleep Quality, and Daily Participation in Subjects With Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
ARTHRITIS CARE & RESEARCH (2010)
Remission in Juvenile Idiopathic Arthritis: Current Facts
Susan Shenoi et al.
Current Rheumatology Reports (2010)
Time to Treatment as an Important Factor for the Response to Methotrexate in Juvenile Idiopathic Arthritis
H. M. Albers et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Do Mothers and Fathers Hold Similar Views About Their Child's Arthritis?
Kathleen Mulligan et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Long-Term Safety and Effectiveness of Etanercept in Children With Selected Categories of Juvenile Idiopathic Arthritis
E. H. Giannini et al.
ARTHRITIS AND RHEUMATISM (2009)
The Myeloid-Related Proteins 8 and 14 Complex, a Novel Ligand of Toll-Like Receptor 4, and Interleukin-1β Form a Positive Feedback Mechanism in Systemic-Onset Juvenile Idiopathic Arthritis
Michael Frosch et al.
ARTHRITIS AND RHEUMATISM (2009)
Development and Validation of a Composite Disease Activity Score for Juvenile Idiopathic Arthritis
Alessandro Consolaro et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
Wilco de Jager et al.
BMC IMMUNOLOGY (2009)
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage
D. Foell et al.
GUT (2009)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Children are not just small adults: The urgent need for high-quality trial evidence in children
Terry P. Klassen et al.
PLOS MEDICINE (2008)
The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis
M. Bartoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
Wilco de Jager et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
Judith A. M. Wessels et al.
ARTHRITIS AND RHEUMATISM (2007)
Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation
NM Wulffraat et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Outcome in adults with juvenile idiopathic arthritis - A quality of life study
HE Foster et al.
ARTHRITIS AND RHEUMATISM (2003)
Share Paper
